048260 — OsstemImplant Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩3tn
- KR₩3tn
- KR₩1tn
- 98
- 29
- 100
- 92
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 147,087 | 164,316 | 277,933 | 216,013 | 277,128 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 106,021 | 111,650 | 104,979 | 226,163 | 167,915 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 362,680 | 397,023 | 504,825 | 612,126 | 687,518 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 222,596 | 338,636 | 367,472 | 426,090 | 523,426 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 637,926 | 797,390 | 958,671 | 1,151,841 | 1,372,321 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 479,643 | 531,561 | 551,819 | 877,245 | 919,036 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 529,304 | 717,359 | 767,007 | 944,692 | 1,029,163 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 108,622 | 80,030 | 191,664 | 207,149 | 343,158 |
Total Liabilities & Shareholders' Equity | 637,926 | 797,390 | 958,671 | 1,151,841 | 1,372,321 |
Total Common Shares Outstanding |